Nipple aspirate fluid: A promising non-invasive method to identify cellular markers of breast cancer risk

British Journal of Cancer

Volumn 76, Issue 4, 1997, Pages 494-501

  Sauter, E R ^a   Ross, E ^a   Daly, M ^a   Klein Szanto, A ^a   Engstrom, P F ^a   Sorling, A ^a   Malick, J ^a   Ehya, H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer risk; Intermediate biomarker; Nipple aspirate fluid

Indexed keywords

CELL MARKER; DNA; DNA MARKER; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASPIRATION; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CELL CYCLE; CLINICAL TRIAL; CYTOLOGY; DIAGNOSTIC PROCEDURE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; NIPPLE; PLOIDY; PRIORITY JOURNAL;

EID: 0030873013     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.415     Document Type: Article

References (15)

1. Agresti A (1990) Categorical Data Analysis. pp. 59-64 and 321-324. Wiley & Sons: New York
2. Dressler LG, Seamer LC, Owens MA, Clark GM and McGuire WL (1988) DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420-427
3. Ellison DA, Maygarden SJ and Nivotny DB (1995) Quantitative DNA analysis of fresh solid tumors by flow and image cytometric methods: a comparison using the Roche Pathology Workstation image analyzer. Modern Path 8: 275-281
4. Giuliano AE (1994) Breast. In Current Surgical Diagnosis & Treatment, Way LW (ed), pp. 293-316. Appleton & Lunge: Norwalk, CT
5. Hollander M and Wolfe DA (1973) Nonparametric Statistical Methods. Wiley & Sons: New York
6. Keynes G (1923) Chronic mastitis. Br J Surg 11: 89-121
7. King EB, Barrett D, King MC and Petrakis NL (1975) Cellular composition of the nipple aspirate specimen of breast fluid. I. The benign cells. Am J Clin Pathol 64: 728-738
8. King EB, Chew KL, Petrakis NL and Ernster VL (1983) Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 71: 1115-1121
9. Leis HP (1991). Prognostic parameters for breast cancer. In The Breast Bland KI and Copeland EM (eds), pp. 331-350. WB Saunders: Philadelphia
10. Liang Y and Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73: 13-22
11. Petrakis NL (1993) Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev 2: 3-10
12. Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S and Catchpool F (1975) Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlaclating women, as determined by nipple aspiration. J Natl Cancer Inst 54: 829-834
13. Sauter ER (1996) Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5: 967-970
14. Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB and Hauck WW (1990) Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 15: 39-51
15. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, Lee MM, Ernster VL, Hilton JF, Schweitzer R, Goodson WH and Hunt TK (1993) Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemol 135: 130-141